Sodium Risedronate Tablets – Special Drug Use Surveillance in Patients With Osseous Paget’s Disease (All-case Surveillance) -48-week Surveillance –
Condition(s):Osseous Paget’s DiseaseLast Updated:June 3, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Osseous Paget’s DiseaseLast Updated:June 3, 2019Completed
Condition(s):OsteoporosisLast Updated:October 19, 2018Completed
Condition(s):OsteoporosisLast Updated:July 30, 2019Completed
Condition(s):Primary OsteoporosisLast Updated:August 2, 2012Completed
Condition(s):Colles’ FractureLast Updated:October 4, 2011Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:March 11, 2008Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:March 11, 2008Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:December 12, 2023Recruiting
Condition(s):Breast CancerLast Updated:January 26, 2011Completed
Condition(s):Osteogenesis ImperfectaLast Updated:September 7, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.